| Date Posted |
Subject |
| Dec. 28, 2005 |
Policies and protocols for post-transfusion assessment of outpatients |
| Dec. 23, 2005 |
What is an acceptable method/practice for tracking the red cell loss of repeat apheresis donors? ADDENDA Dec. 23, 27 & 28 |
| Dec. 22, 2005 |
Criteria for selection of plasma products when performing therapeutic plasma exchange for TTP patients ADDENDA Dec. 23, 27 & 28 |
| Dec. 21, 2005 |
Increasing the visibility of the Circular of Information ADDENDA Dec. 22 |
| Dec. 21, 2005 |
Limiting RHIG prophylaxis based on prenatal determination of fetal Rh status ADDENDA Jan. 2, 2006 |
| Dec. 14, 2005 |
REACTIVATED DISCUSSION: How best to manage plasma products that are returned unused and how to minimize wastage of plasma products. Sept. 18, 2001; ADDENDUM Sept. 19 & Dec. 14, 2005 |
| Dec. 13, 2005 |
Is there any reason to defer donors with hemoglobin J variant? ADDENDA Dec. 14 |
| Dec. 8, 2005 |
Fatalities due to ABO hemolytic reactions ADDENDA Dec. 13 & 14; Jan. 2 & 3, 2006 |
| Dec. 6, 2005 |
REACTIVATED DISCUSSION: Complications of citrate toxicity in otherwise healthy allogeneic stem cell donors Oct. 10, 2001; ADDENDA Oct. 10, 2001; Dec. 6, 10, 13 & 14, 2005 |
| Dec. 5, 2005 |
Policies and practices regarding transfusion of febrile patients ADDENDA Dec. 6, 7, 8 & 13 |
| Nov. 21, 2005 |
What
is the correct procedure for decommissioning
an outdated blood product irradiator? ADDENDA Nov.
23 & Jan.
22 & Aug. 4 & 31; Nov. 9 & 13, Dec. 8, 2006; June 22 & 27,
July 11, Aug. 2, 2007 |
| Nov. 15, 2005 |
Experience in the preparation of platelet gel, including for use in skin ulcer repair for Scleroderma |
| Nov. 8, 2005 |
REACTIVATED DISCUSSION: Problems Spiking Sides of Blood Bags? May 30, 2000; ADDENDA Nov. 8 & 11, 2005 |
| Oct. 27, 2005 |
Accreditation and criteria for development of a "bloodless" hospital or surgery center ADDENDA Oct. 28, 31 & Nov. 7 |
| Oct. 25, 2005 |
Is it appropriate to have separate transfusion guidelines for 'cardiac patients' and/or for those undergoing specific diagnostic or therapeutic procedures? ADDENDA Oct. 28 & Nov. 8 |
| Oct. 25, 2005 |
Transfusion practice review for oncology patients |
| Oct. 17, 2005 |
Use of CMV serologically tested CMV negative FFP ADDENDA Oct. 19 & 21 |
| Oct. 7, 2005 |
REACTIVATED DISCUSSION: Should a test for fetomaternal hemorrhage (FMH) be done before administering Rh Immune Globulin to Rh-negative women at risk of FMH in early pregnancy? Oct. 22, 2002; ADDENDA Oct. 23; Oct. 7, 26 & 28, 2005 |
| Oct. 4, 2005 |
Policies for provision of RBC units for transfusion at "off-site" physician offices ADDENDA Oct. 7 |
| Oct. 3, 2005 |
REACTIVATED DISCUSSION: The practice of transfusing out-of-type platelets May 10, 2002; ADDENDA May 11, 13 & 14; Sept. 2, 8, 20 & 29, 2002; Oct. 3, Nov. 1 & 2, 2005 |
| Oct. 3, 2005 |
REACTIVATED DISCUSSION: What is the frequency of hemolytic reactions associated with transfusion of plateletpheresis units containing ABO incompatible plasma? Aug. 27, 2003; ADDENDA Aug. 28, Sept. 3, 5 & 9; Sept. 2, 8, 20 & 29, 2003; Oct. 3, 2005 |
| Oct. 3, 2005 |
QC checks for ABO typing reagents; what
is required for compliance with rules/regulations
versus what is needed to assure test results
are accurate for patients who might need transfusion? ADDENDA Oct.
4; Nov. 22, 2007 |
| Sept. 23, 2005 |
The efficacy of aprotinin and the ethics of further Randomized Clinical Trials to assess that efficacy ADDENDA Nov. 29 |
| Sept. 22, 2005 |
Should plasma products be thawed only in dedicated water baths, or may those also utilized for other laboratory applications be used? ADDENDA Oct. 17 |
| Sept. 19, 2005 |
Techniques and methods used for fungal cultures of Hematopoietic Progenitor Cells, Apheresis (HPC-A), and Marrow (HPC-M) ADDENDA Sept. 20 & 22 |
| Sept. 14, 2005 |
Availability of and experience with Fetal RhD genotype testing ADDENDA Sept. 21 |
| Sept. 14, 2005 |
Labeling hematopoietic progenitor cells ADDENDA Sept. 15 & 22 |
| Sept. 9, 2005 |
Experience with the use of "amniopatch" treatment for Premature Prelabour Rupture of Membrane (PROM) ADDENDA Sept. 13 |
| Sept. 9, 2005 |
Transfusion support of patients who require transplantation of ABO incompatible solid organs ADDENDA Sept. 10 |
| Sept. 7, 2005 |
Methods to accurately quantify platelets in apheresis units ADDENDA Sept. 14 & 20 |
| Sept. 1, 2005 |
Proficiency testing requirements for hemoglobin testing performed in donor suitability determination |
| Aug. 28, 2005 |
How long do indications for irradiated blood products continue for patients achieving a "cure" of the originally qualifying condition? ADDENDA Sept. 1 |
| Aug. 28, 2005 |
Indications for selecting 'sickle negative' donor RBC units for transfusion ADDENDA Sept. 1 & 2 |
| Aug. 20, 2005 |
Is it acceptable practice to transfuse platelets through a rapid flow blood and fluid warming device? ADDENDA Aug. 21 & 24; June 20 & July 1, 2008 |
| Aug. 13, 2005 |
Experience in the use of infrared thermometers to measure the temperature of blood products ADDENDA Aug. 16 |
| Aug. 13, 2005 |
Is it a requirement for donor reactions to be investigated to determine a probable cause? |
| Aug. 12, 2005 |
REACTIVATED DISCUSSION: Protocols
for the detection and treatment of TRALI Dec. 2, 2003; ADDENDA Dec.
3, 4, 10, 12 & 16; Jan. 2, 2004; Aug. 12, 2005; Mar. 19 & 30, 2008 |
| Aug. 10, 2005 |
Adverse events associated with the serial administration of ABO non-identical cryo and RBCs through the same blood administration tubing ADDENDA Aug. 13, 15, 17, 18 & 19 |
| Aug. 7, 2005 |
Does elimination of paper test requisitions accompanying pre-transfusion samples increase the risk of an ABO incompatible transfusion, since there would be no independent means to verify the accuracy of a specimen label? ADDENDA Aug. 12 & 13 |
| Aug. 5, 2005 |
Do transfusion service laboratories with automated equipment use the same QC reagents for the daily QC of their automated equipment and for the rack(s) of reagents that might be used in manual testing, in the event the automated equipment malfunctions? |
| Aug. 3, 2005 |
REACTIVATED DISCUSSION: Autologous Units Positive for ID Markers - Should they be collected and made available for transfusion? June 6, 2001; ADDENDA June 7 & 12, 2001; Aug. 6. 2005; Mar. 22, 2009 |
| Aug. 3, 2005 |
Reporting of Critical Values by transfusion service laboratories ADDENDA Aug. 4, 5, 6, 8 & 10; Sept. 14 & 15 |
| Aug. 3, 2005 |
Should irradiated blood products be used for patients receiving anti-Tumor Necrosis Factor (TNF) agents? ADDENDA Aug. 5 |
| Aug. 1, 2005 |
Interpretation of a notice from the California Board of Vocational Nursing and Psychiatric Technicians to Blood Banks and Pheresis Settings |
| Aug. 1, 2005 |
Are staff required to wear gloves when collecting blood donations from healthy donors? (revisited) ADDENDA Aug. 2 & 15 |
| July 30, 2005 |
Is it necessary to periodically mix a unit of RBCs that is being transfused by squeezing the blood bag every 20-30 minutes? |
| July 28, 2005 |
Determining the risk of HIV or HCV infection in donors with indeterminate confirmatory or supplementary tests ADDENDA July 29, 31 & Aug. 3 |
| July 26, 2005 |
Definition of post donation illness qualifying for 120 day "possible" West Nile Virus deferral |
| July 25, 2005 |
Reconstituting Whole BloodADDENDA July 26 |
| July 25, 2005 |
Possible reaction following automated double red cell collection ADDENDA July 25 |
| July 21, 2005 |
Blood usage during total hip replacements ADDENDA July 25 & 26 |
| July 14, 2005 |
Routine use of cryoprecipitate to reverse prolonged protime and INR prior to heart surgery ADDENDA July 19 & 21; Aug. 10 |
| July 8, 2005 |
Problems in the operating room with labeling blood specimens intended for pre-transfusion compatibility testing ADDENDA July 12 |
| July 8, 2005 |
A survey on the use of social security numbers to identify volunteer blood donors ADDENDA July 21 |
| July 5, 2005 |
Qualifying repeat platelet pheresis donors with regards to platelet counts when collecting from individuals donating more frequently than every 8 weeks |
| June 30, 2005 |
REACTIVATED DISCUSSION: What do blood collection centers do with donors who are implicated in TRALI, and those whose blood is at high risk of causing TRALI? Jan. 7, 2004; ADDENDA July 30 & June 3, 2005 |
| June 30, 2005 |
Experience in using GEL methodology for extended RBC antigen phenotyping ADDENDA July 7, Aug. 2, Oct. 28 & 31 |
| June 24, 2005 |
Provision of A1 and B reagent red cells negative for M and Lewis antigens ADDENDA June 28 & July 4 |
| June 16, 2005 |
The case for limiting transfusions to ABO identical red cells/ platelets/ FFP/ cryoprecipitate and avoiding transfusion of incompatible cell associated or soluble antigen or isoagglutinins ADDENDA June 20, 22 & 23 |
| June 14, 2005 |
Evaluating the e-Network Forum and CBBS Website |
| June 14, 2005 |
Use of platelets for intrauterine transfusions ADDENDA July 7 |
| June 7, 2005 |
Experience and/or collected data regarding the use of oxygen in treating reactions associated with blood donation |
| May 25, 2005 |
Detection of mutant examples of HBsAg ADDENDA May 26 |
| May 24, 2005 |
Assessing the hemostatic quality of platelet products ADDENDA May 31 |
| May 23, 2005 |
How do hospital transfusion service laboratories perform quality control (QC) testing for reagent red cells that are part of an antibody identification panel? ADDENDA May 31, June 1 & Aug. 21 |
| May 18, 2005 |
Importing historical unit information when migrating from a "home-grown" blood bank information system to a commercial system ADDENDA May 20 |
| May 18, 2005 |
Does an unlicensed, unregistered transfusion service need to report Biological Product Deviations to the FDA? ADDENDA May 18 |
| May 11, 2005 |
Is it acceptable to transfer compatibility testing samples and crossmatched RBC units between networked facilities? ADDENDA May 14 |
| May 3, 2005 |
Preparation, storage and expiration of pooled plasma used for TPE procedures ADDENDA May 4, 5 & 10 |
| May 3, 2005 |
Blood grouping prerequisites for electronic crossmatching in a fully automated environment (including electronic transfer of results) ADDENDA May 4, 8 & 10 |
| April 29, 2005 |
Patient identification systems for use in mass casualty disasters ADDENDA May 3 |
| April 27, 2005 |
Strategies to assure that blood receives proper irradiation dosage ADDENDA Apr. 28 & 29 |
| April 27, 2005 |
Stability of ADAMTS13 in thawed cryoprecipitate poor plasma (CPP) stored for more than 24 hours ADDENDA Apr. 27; Dec. 24, 2006 |
| April 25, 2005 |
Deferral policies for prospective platelet apheresis donors taking herbal supplements |
| April 23, 2005 |
How to find a rare RBC unit for transfusion of a patient who has an antibody to a high prevalence antigen or multiple red cell antibodies ADDENDA May 3 |
| April 22, 2005 |
Eligibility of a prospective blood donor who has an intrathecal morphine pump for spinal disk pain ADDENDA Apr. 26 |
| April 14, 2005 |
Should plateletpheresis donors be routinely screened for evidence of platelet dysfunction? ADDENDA Apr. 25 & 26 |
| April 12, 2005 |
REACTIVATED DISCUSSION: Administering antipyretics and antihistamines to prevent febrile reactions to blood transfusion Nov. 18, 2003; ADDENDA Nov. 19, 20 & 28, 2003; Apr 12 & 13, 2005 |
| April 10, 2005 |
Compliance with Current Good Tissue Practice for Human Cell, Tissue, and Cellular and Tissue-Based Product Establishments ADDENDA Apr. 10 & 21 |
| April 7, 2005 |
Should CMV safe blood components be provided for transfusion to post-partum women? |
| April 5, 2005 |
Pre-Transfusion Testing: Managing a second sample that arrives while a current sample remains acceptable ADDENDA Apr. 8 |
| April 1, 2005 |
Under what circumstances can an individual who lost a kidney due to trauma be an eligible blood donor? ADDENDA Apr. 2 & 8 |
| Mar. 29, 2005 |
What is the appropriate action to take when a monitored device has repeated alarm activations? ADDENDA Mar. 31 & Apr. 2 |
| Mar. 28, 2005 |
What is an effective strategy to assure that a blood product dispensed via a pneumatic tube system is administered to the correct recipient? ADDENDA Sept. 12 & 18, 2006; Feb. 26, 2007 |
| Mar. 28, 2005 |
Should there be arbitrary triggers for transfusing brain-dead potential organ donors? ADDENDA Mar. 29; REACTIVATED Oct. 3 |
| Mar. 27, 2005 |
Should pH and glucose testing of single-donor apheresis platelets be discontinued in favor of a more sensitive detection method? |
| Mar. 23, 2005 |
REACTIVATED DISCUSSION: A call for "benchmark" data for peer review of blood utilization April 3, 2002; ADDENDA April 4 & 5, 2002; Mar 23, 29 & April 6, 2005; Oct. 12, 2008 |
| Mar. 22, 2005 |
Interpretation of AABB Standards for pre-transfusion compatibility testing of two-unit red cell apheresis products from the same donation ADDENDA Mar. 23 |
| Mar. 21, 2005 |
Experience in the use of THAWED PLASMA ADDENDA Mar. 21, 22, 23 & Apr. 3; Mar. 1, 6, 7 & 17, 2007 |
| Mar. 21, 2005 |
Suitability of patients with sickle cell disease for intraoperative cell salvage ADDENDA Mar. 23 |
| Mar. 15, 2005 |
Use of leukoreduced autologous blood products ADDENDA Mar. 16 & 19 |
| Mar. 13, 2005 |
Proficiency testing for urine dipstick method to detect bacteria in platelet concentrates ADDENDA Mar. 14 |
| Mar. 10, 2005 |
Policies for testing donors, patients and pregnant women for the DVI Rh variant (a form of weak D) ADDENDA Mar. 16 |
| Mar. 9, 2005 |
Addressing the proposed new requirements for verification of donor-recipient ABO compatibility in organ procurement and transplantation ADDENDA Mar. 10 |
| Mar. 8, 2005 |
REACTIVATED DISCUSSION: Protocols for 'identifying' unidentified trauma patients who need emergency transfusion ADDENDA Oct. 15, 2003; Oct. 16 & 29; Nov. 7; Mar 8 & 9, Apr 13, 2005 |
| Mar. 7, 2005 |
Bedside checks of ABO/Rh compatibility before transfusion of red cells ADDENDA Mar. 10 |
| Mar. 3, 2005 |
When is a very slow pulse rate in a healthy appearing young man cause for concern? |
| Feb. 27, 2005 |
How do blood
banks know when a patient should get irradiated
blood, if the patient's doctor forgets to order
the blood to be irradiated? ADDENDA Feb.
28; Mar. 1, 7 & 8, 2005; Apr. 17, 19, 21 & 23; May 25; June
16, 2006; Dec. 29, 2007; Jan. 10, 2008 |
| Feb. 22, 2005 |
New approaches to increasing blood donations in the public sector ADDENDA Feb. 23, 24 & 28 |
| Feb. 21, 2005 |
Strategies for selecting best Rh phenotype for intrauterine red cell transfusion for reasons other than hemolytic disease of the newborn ADDENDA Feb. 28 |
| Feb. 20, 2005 |
Should taking selective serotonin reuptake inhibitors (SSRIs) be a factor in donor selection and/or the products manufactured from such a donation? ADDENDA Mar. 4 |
| Feb. 17, 2005 |
Experience in using barcoded wristband systems ADDENDA Feb. 19, 23, 24; Apr. 11 & 14 |
| Feb. 10, 2005 |
Strategies for antigen typing an alleged "father" of a fetus whose mother has developed alloantibodies capable of causing hemolytic disease of the newborn ADDENDA Feb. 14 |
| Feb. 9, 2005 |
Selection of donor RBC units for infants with ABO grouping discrepancies ADDENDA Feb. 12 |
| Feb. 9, 2005 |
Acceptability of a stem-cell donor with uncertain Rh typing results |
| Feb. 6, 2005 |
What is the minimum safe platelet count prior to spinal anesthesia in the absence of thrombocytopathy? ADDENDA Feb. 8 & 10 |
| Feb. 6, 2005 |
Does Biologic Product Deviation Reporting for Human Cells, Tissues and Cellular and Tissue-Based Products (HCT/P) include non-human source tissue, such as skin grafts? ADDENDA Feb. 8 |
| Jan. 24, 2005 |
Programs to monitor the risk of misidentifying pretransfusion blood samples |
| Jan. 22, 2005 |
Terminology to use when no crossmatch compatible RBCs are available ADDENDA Jan. 25, 26 & 29 |
| Jan. 17, 2005 |
Practical concerns with the irradiation of Red Cells either before or after they have been frozen (and thawed) ADDENDA Jan. 18 & 24 |
| Jan. 11, 2005 |
Methods for quantitating fetal red cells in maternal blood ADDENDA Jan. 12, 13, 18 & 30 |
| Jan. 10, 2005 |
Use of rapid infusion devices for transfusion in childhood trauma cases ADDENDA Oct. 2 & Nov. 4, 2008 |
| Jan. 9, 2005 |
Pre-infusion crossmatching of heparinized allogeneic bone marrow |
| Jan. 9, 2005 |
Donor RBC selection for group A2 (or group A2B) individuals who have anti-A1 ADDENDA Jan. 10 |
| Jan. 7, 2005 |
Tracking filters used with blood products ADDENDA Jan. 8, 9, 11, 14 & 18, Feb. 1, Mar. 16; Apr. 5 & 6 |
| Jan. 3, 2005 |
Medical criteria for exclusion of umbilical cord blood donation ADDENDA Jan. 10 |
| Jan. 3, 2005 |
Autologous donation by a patient whose red cells show a positive direct antiglobulin test ADDENDA Jan. 3 & 4; Sept. 14 |
Back to Top 
The e-Network Forum is supported in part by the California Blood Bank Society (CBBS) and the American Red Cross Blood Services (ARCBS) and endorses collegial discussion among blood banking and transfusion medicine professionals. However, neither the CBBS nor the ARCBS in any way endorse the specific views and opinions expressed in the forum. The forum is not intended as a substitute for medical or legal advice and the content should not be relied upon for any medical or legal purposes. Readers should make their own determinations as to: (i) what constitutes appropriate medical, technical, and administrative practices, and (ii) how best to comply with laws and regulations relevant to their questions. For the latter, they should consider consulting, as to any medical matters, a qualified physician, and, as to any legal matters, an attorney familiar with related state and federal laws. The user of the forum, by accessing same, assumes all risks arising out of such use and releases CBBS and their respective members, directors, officers and agents from and against any loss, damage, claim or liability arising out of such use of the Forum.
